EUVIMEDEUVIMED entdecken
Crossref

Real-world effectiveness and safety of tocilizumab in the management of polymyalgia rheumatica: a retrospective study from the KEIO-PMR cohort

Yuki Imai, Satoshi Takanashi, Yuko Kaneko

Rheumatology International · 2025

DOI: 10.1007/s00296-025-05941-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology International, 2025. Verfasst von Yuki Imai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Polymyalgia Rheumatica, Antibodies, Monoclonal, Humanized, Glucocorticoids, Immunosuppressive Agents. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyalgia RheumaticaAntibodies, Monoclonal, HumanizedGlucocorticoidsImmunosuppressive AgentsHumansFemaleRetrospective StudiesAgedMaleTreatment OutcomeRecurrenceMiddle AgedAged, 80 and overC-Reactive Protein

Stichwörter der Autor:innen

GlucocorticoidsInterleukin-6Polymyalgia rheumaticaRecurrenceTocilizumab

Substanzen

tocilizumabAntibodies, Monoclonal, HumanizedGlucocorticoidsImmunosuppressive AgentsC-Reactive Protein

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
  • Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. ykaneko.z6@keio.jp.

Zitieren

APA

Imai, Y., Takanashi, S., & Kaneko, Y. (2025). Real-world effectiveness and safety of tocilizumab in the management of polymyalgia rheumatica: a retrospective study from the KEIO-PMR cohort. Rheumatology International. https://doi.org/10.1007/s00296-025-05941-0

Vancouver

Imai Y, Takanashi S, Kaneko Y. Real-world effectiveness and safety of tocilizumab in the management of polymyalgia rheumatica: a retrospective study from the KEIO-PMR cohort. Rheumatology International. 2025. doi:10.1007/s00296-025-05941-0

BibTeX
@article{Imai2025,
  author = {Imai, Yuki and Takanashi, Satoshi and Kaneko, Yuko},
  title = {Real-world effectiveness and safety of tocilizumab in the management of polymyalgia rheumatica: a retrospective study from the KEIO-PMR cohort},
  journal = {Rheumatology International},
  year = {2025},
  doi = {10.1007/s00296-025-05941-0}
}
Kostenlos starten →